Reitz Capital Advisors’s Zomedica Corp. ZOM Stock Holding History

Reitz Capital Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$4.61K	Hold	23,000	–	–	0.01%	22
2023 Q4	$4.61K	Hold	23,000	–	–	0.01%	24
2023 Q3	$3.88K	Hold	23,000	–	–	0.01%	45
2023 Q2	$4.6K	Hold	23,000	–	–	﹤0.01%	47
2023 Q1	$4.87K	Hold	23,000	–	–	﹤0.01%	52
2022 Q4	$4K	Buy	23,000 +500	+2%	+$102	﹤0.01%	49
2022 Q3	$5K	Buy	22,500 +7,500	+50%	+$1.99K	﹤0.01%	47
2022 Q2	$3K	Hold	15,000	–	–	﹤0.01%	53
2022 Q1	$5K	Sell	15,000 -450	-3%	-$147	﹤0.01%	76
2021 Q4	$13K	Buy	15,450 +2,050	+15%	+$923	0.01%	49
2021 Q3	$7K	Sell	13,400 -2,050	-13%	-$1.21K	0.01%	47
2021 Q2	$13K	Buy	+15,450	New	+$14.4K	0.01%	49

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Atom Investors Austin, Texas $1.12B AUM 38.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Reitz Capital Advisors's ZOM Position: Q1 2024 in Review

Reitz Capital Advisors held its Zomedica Corp. (ZOM) position steady in Q1 2024 at 23,000 shares worth $4.61K. The position accounts for 0.01% of the portfolio, ranked #22.

Reitz Capital Advisors first reported a position in ZOM in Q2 2021 and has held it in 12 quarters since. The position peaked at $13K in Q4 2021. 100 funds tracked by Wall St. Rank hold ZOM as of Q1 2024.

Reitz Capital Advisors held 23,000 shares of Zomedica Corp. worth $4.61K as of Q1 2024.
Reitz Capital Advisors left its Zomedica Corp. share count unchanged in Q1 2024.
Zomedica Corp. made up 0.01% of Reitz Capital Advisors's portfolio in Q1 2024, its #22 holding.
Reitz Capital Advisors first reported a position in Zomedica Corp. in Q2 2021 and has held it in 12 quarters since.
Reitz Capital Advisors's Zomedica Corp. position peaked at $13K in Q4 2021.
100 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2024.

Based on Reitz Capital Advisors's 13F filing for Q1 2024, filed 22 Apr 2024.